Artificial intelligence and big data are revolutionizing biotech and healthcare, driving breakthroughs in precision medicine, clinical decision-making, and drug discovery.
This panel will showcase how adaptive or autonomous AI models enhance decision-making and improve industry performance and productivity.
Additionally, the discussion will emphasize the importance of robust AI infrastructure in creating scalable, high-performance healthcare solutions, while also highlighting the necessity of strong, high-quality data for accurate AI concepts.
Experts will delve into advancements in clinical development productivity, patient data analytics, AI-powered diagnostics, and the agent-based concepts, while also highlighting local initiatives designed to foster collaboration and innovation in healthcare AI.
May 5, 16:45 -17:45, room Montreal
| Name | Position | Institution |
|---|---|---|
| Pablo Nieto | Principal | IQVIA |
| Name | Position | Institution |
|---|---|---|
| Eva-Maria Hempe | Head of Healthcare and Life Sciences EMEA | NVIDIA |
| Erwin Böttinger | Director | Wyss Center for Bio and Neuroengineering |
| Tom Baker | SVP and GM | IQVIA Switzerland & Israel |
| Philippe Menu | EVP, Chief Medical Officer & Chief Product Officer | SOPHiA GENETICS |
